Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yield
AssigneeDimension Therapeutics, Inc.
InventorsYing Jing, Mingyang Jiang, Kelly Reed Clark
Life of this patent
Estimating the term…
Abstract
The invention provides methods for the production of recombinant adeno-associated virus vectors (rAAV), comprising contacting a host cell with a solution comprising a glucocorticoid analog, such as dexamethasone. Also provided are methods for increasing the production of rAAV by a host cell, comprising contacting a host cell with a solution comprising a glucocorticoid analog, such as dexamethasone.
Claims30
A method for producing a recombinant adeno-associated virus vector (rAAV) comprising contacting a host cell with a solution comprising a glucocorticoid analog.
A method for increasing the amount of recombinant adeno-associated virus vector (rAAV) produced by a host cell, comprising contacting the host cell with a solution comprising a glucocorticoid analog.
A composition comprising a host cell and a glucocorticoid analog.
Dependencies are inferred from the claim text.